Navigation Links
Driven by Sales of Lyrica, Cymbalta/Xeristar and Savella, the Fibromyalgia Drug Market Will Experience 4.2 Percent Annual Growth Through 2018
Date:9/8/2010

BURLINGTON, Mass., Sept. 8 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that increasing use of U.S. regulatory-approved agents -- Pfizer's Lyrica (pregabalin), Eli Lilly/Boehringer Ingelheim's Cymbalta/Xeristar (duloxetine) and Forest Laboratories' Savella (milnacipran) -- will drive 4.2 percent annual growth in the fibromyalgia drug market from 2009 to 2018. However, owing to the generic entry of sales-leading pregabalin, the market will decline sharply from $1.8 billion in 2018 to only $1.4 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The Pharmacor 2010 findings from the topic entitled Fibromyalgia reveal that an expanding drug-treated population, resulting from increasing diagnosis rates, will fuel annual market growth over the next several years in the world's major pharmaceutical markets. While the United States will account for more than two-thirds of major-market fibromyalgia drug sales in 2019, market expansion in Europe and Japan will be constrained by a dearth of approved therapies, lower diagnosis rates and less widespread recognition of the disorder.

The findings also reveal that duloxetine is now in close competition with pregabalin for market-leading status in the United States.

"Although pregabalin was the U.S. patient- and market-share leader in 2009, patient share of duloxetine grew significantly last year," said Decision Resources Analyst Andrea Buurma. "Sales of duloxetine are not projected to surpass pregabalin sales during our forecast period, owing in large part to market entry of generic duloxetine in the United States in 2013; however, we do expect duloxetine to supplant pregabalin as the U.S. patient-share leader by 2015."

The Pharmacor 2010 findings also reveal that, in light of the recent recommendation by an FDA advisory committee ag
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Increasing Potential for RIS-driven PACS Modules in Europe, Finds Frost & Sullivan
2. New Study Shows Meganuclease-Driven Targeted Integration Using Cellectis bioresearchs cGPS® CHO-K1 Kit to be Highly Efficient for Drug Discovery
3. GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
4. Energetiq Introduces Laser-Driven Light Sources for Biophysical Applications
5. The Cancer Pain Drug Market, Driven by the Continued Dominance of Opioids, Will Increase From $2.3 Billion in 2008 to $3.7 Billion in 2018
6. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
7. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
8. Reportlinker Adds Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge
9. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
10. Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010
11. Kewaunee Scientific Reports Sales and Earnings for First Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... BURLINGTON, Mass. , Sept. 18, 2014  Decision ... launched anti-vascular endothelial growth factor (VEGF) agent for wet ... and Medicare Advantage plans as Genentech,s Lucentis, which is ... although surveyed managed care organization (MCO) directors do not ... Eylea is slightly more likely than Lucentis to be ...
(Date:9/18/2014)... Pa. , Sept. 18, 2014 /PRNewswire/ ... solutions, was recognized as the Disruptive Innovator ... its ePharmaONE cloud-based eClinical platform. This solution ... electronic trial master file (eTMF), a remote ... and ePharmaSolutions, ReferralPlus+ patient screening and matching ...
(Date:9/18/2014)... Sept. 18, 2014  A $3 million grant from ... University of Michigan to establish a national center of ... Center for Aging Research at U-M will focus on ... slow the effects of aging and postpone diseases in ... that can help develop medications that may help people ...
Breaking Medicine Technology:Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 2ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3
... bolstering current systems for assessing and monitoring drug safety, researchers ... combines multiple forms of widely available data to predict adverse ... of drug safety issues as they accumulate over time in ... issues years in advance. This study, led by ...
... Food and Drug Administration is warning consumers again not to ... and sold by various companies, due to serious potential health ... Massager is a personal massage device sold in retail ... provide users with a deep tissue massage to the neck, ...
Cached Medicine Technology:Taking a Predictive Approach to Identifying Adverse Drug Reactions 2Taking a Predictive Approach to Identifying Adverse Drug Reactions 3FDA: Do Not Use ShoulderFlex Massagers 2FDA: Do Not Use ShoulderFlex Massagers 3
(Date:9/18/2014)... 2014 (HealthDay News) -- Older people become more physically ... the balance of stress hormones during bereavement changes with ... who are grieving are more likely to have weakened ... "During the difficult weeks and months after loss, we ... most abundant type of white blood cell and as ...
(Date:9/18/2014)... San Luis Obispo, CA (PRWEB) September 18, 2014 ... Bunion Bootie introduced their newest, patent pending bunion splint ... , As one loyalist, Rosa, wrote: "I was absolutely delighted. ... comfortable... I honestly forget I am wearing them. THANK YOU ... the recently introduced design by saying, "The hole used to ...
(Date:9/18/2014)... Mozes HealthDay Reporter , THURSDAY, ... emergency room waiting times, patients seeking care at larger urban ... clock than those seen at smaller or more rural facilities, ... ability to provide timely emergency care varies dramatically across hospitals ... the new research, Dr. Renee Hsia, an associate professor at ...
(Date:9/18/2014)... Chest Physicians (CHEST) together with the Chinese Thoracic ... of CTS that CHEST World Congress 2016 will ... critical care, and sleep medicine from around the ... slated for spring 2016. , CHEST World ... hands-on simulation training, keynote addresses, presentations by leading ...
(Date:9/18/2014)... Seattle, WA (PRWEB) September 18, 2014 ... management organizations, has published a white paper, “Advancing ... Optimization of Health Information Technology.” , Authors Jeff ... PCMH CCE provide guidance to organizations engaged in the ... showing how health IT can bolster PCMH objectives, such ...
Breaking Medicine News(10 mins):Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:CHEST announces China as site of CHEST World Congress 2016 2Health News:Advancing Primary Care Through PCMH and HIT: New White Paper Connects the Dots 2
... recipient,s tissue, study finds, , SUNDAY, Nov. 22 (HealthDay ... -- a missing gene -- boosts the risk that ... complication called graft-versus-host disease. , The immune system-related ... variation and the donor does not. , When ...
... ... can be both fun and joyous. It can also be stressful and tiring ... foods -- factors that can, over time, increase your risk of cancer. That,s ... 10 Food Tips that can help ensure a happier, more healthful holiday season, ...
... WASHINGTON, Nov. 21 Tonight, in a partisan vote, the ... the government takeover of health care. Among the several objectionable ... and individual mandates, is the government funding for elective abortion, ... bill provides subsidies for private plans that cover elective abortion. ...
... Nov. 21 Milvia Lopez, by her attorney MICHAEL STEWART ... Court, New York County, bearing Index # 112888/2009. The complaint ... ("TEE") at ST. VINCENT,S HOSPITAL , doctors used an ... The complaint alleges that several hours after being discharged from ...
... , LONDON, November 21, 2009 Test Test Test ... Test Test,Test Test Test Test Test Test Test Test Test Test Test Test ... Test , More test More test More test More ... test More test More test More test More,test More test , , ...
... ... available on the iPhone and iPod Touch. , ... Mountain View, CA (PRWEB) November 21, 2009 -- HAPPYneuron,s most popular and ... designed to help banish that ,tip of the tongue, syndrome forever. , , ,The SplitWords ...
Cached Medicine News:Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3
... 4, 8, or 12 channel pipettors. Angled sides ... of the solution. Corners have pouring lips to ... polystyrene containing no regrinds. Sterile 5/bag packaging for ... mm W x 152 mm L x 35 ...
Volume: 10 ml; Volume Graduation: 1/10 ml...
... Gilsons Pipette Aid, which is for use ... rapidly, and comfortably with precision. It works with ... the volume range from 1 mL to 100 ... valve and replaceable membrane filters, which protect the ...
Inquire...
Medicine Products: